These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2109524)

  • 1. Cardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator.
    Gertz SD; Kalan JM; Kragel AH; Roberts WC; Braunwald E
    Am J Cardiol; 1990 Apr; 65(15):953-61. PubMed ID: 2109524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators.
    Gertz SD; Kragel AH; Kalan JM; Braunwald E; Roberts WC
    Am J Cardiol; 1990 Oct; 66(12):904-9. PubMed ID: 2121015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
    Tiefenbrunn AJ; Chandra NC; French WJ; Gore JM; Rogers WJ
    J Am Coll Cardiol; 1998 May; 31(6):1240-5. PubMed ID: 9581714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reperfusion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (National Registry of Myocardial Infarction-2).
    Peterson LR; Chandra NC; French WJ; Rogers WJ; Weaver WD; Tiefenbrunn AJ
    Am J Cardiol; 1999 Dec; 84(11):1287-91. PubMed ID: 10614792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy.
    Waller BF; Rothbaum DA; Pinkerton CA; Cowley MJ; Linnemeier TJ; Orr C; Irons M; Helmuth RA; Wills ER; Aust C
    J Am Coll Cardiol; 1987 Apr; 9(4):785-801. PubMed ID: 2951422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.
    TIMI Study Group
    N Engl J Med; 1989 Mar; 320(10):618-27. PubMed ID: 2563896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction].
    Gao R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Aug; 19(4):228-30, 267-8. PubMed ID: 1813288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with intracoronary tissue plasminogen activator: results of a multicenter registry. Intracoronary t-PA Registry Investigators.
    Cathet Cardiovasc Diagn; 1995 Mar; 34(3):196-201. PubMed ID: 7497484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty.
    Passamani E; Hodges M; Herman M; Grose R; Chaitman B; Rogers W; Forman S; Terrin M; Knatterud G; Robertson T
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):51B-64B. PubMed ID: 2889758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count.
    Vrachatis AD; Alpert MA; Georgulas VP; Nikas DJ; Petropoulou EN; Lazaros GI; Michelakakis NA; Karavidis AI; Lakoumentas JA; Stergiou L; Zacharoulis AA
    Angiology; 2001 Mar; 52(3):161-6. PubMed ID: 11269778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with low-dose intracoronary recombinant tissue-type plasminogen activator for nonacute total occlusions before percutaneous transluminal coronary angioplasty.
    Ruocco NA; Currier JW; Jacobs AK; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Dec; 68(17):1609-13. PubMed ID: 1746461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
    Zeymer U; Schröder R; Machnig T; Neuhaus KL
    Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tissue plasminogen activator therapy on the frequency of acute right ventricular myocardial infarction associated with acute left ventricular infarction.
    Kalan JM; Gertz SD; Kragel AH; Berger PB; Roberts WC; Ryan TJ
    Int J Cardiol; 1993 Feb; 38(2):151-8. PubMed ID: 8454377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple coronary thromboemboli and myocardial infarction in a newborn infant.
    Lucas VW; Burchfield DJ; Donnelly WH
    J Perinatol; 1994; 14(2):145-9. PubMed ID: 8014700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-ranging study with a new two-chain rt-PA in patients with acute myocardial infarction: a multicenter trial.
    DeWood MA; Kurnik PB; Jolly MK; Jain AC; Khaja F; Gorfinkel HJ; Morris DL; Satler L; LittleJohn J
    Clin Cardiol; 1993 Apr; 16(4):302-10. PubMed ID: 8458110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
    N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators.
    Cox DA; Rogers WJ; Aguirre FV; Forman S; Solomon R; Zaret BL
    Am J Cardiol; 1994 Apr; 73(11):729-36. PubMed ID: 8160607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.